Atrial Fibrillation & Coumadin® Replacements– interviews Dr. Manish Shah

Dr. Manish Shah talks about Dabigatran and Rivaroxaban, new drugs in clinicals trials to replace the blood thinner Coumadin® (warfarin), an anticoagulant frequently used to avoid strokes by those with atrial fibrillation. He talks about the two categories of these new drugs, thrombin inhibitors and Factor Xa (10a) inhibitors. Dr. Shah is Associate Director of Cardiac Arrhythmia Research at the Washington Hospital Center in Washington, DC, and Assistant Professor of Medicine at Georgetown University School of Medicine., at, is for atrial fibrillation patients by afib patients. A full video transcript can be found at

Leave a Reply

Fields marked with * are required.